Lac & Usc Medical Center

Los Angeles, California 90089

1 studies enrolling now · 74 studies all time

What they study most

2nd Degree Burn of the Skin, ACUTE LYMPHOBLASTIC LEUKEMIA, Acute Coronary Syndrome (ACS), Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenoma, Adenoma Colon, Advanced Cancer, Advanced Solid Tumors, Alcoholic Hepatitis, Anxiety State, Apnea of Prematurity

Studies at this site

• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States — Recruiting now
• A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
• Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors — Running, not enrolling
• Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors. — Completed
• Liver Cirrhosis Network Cohort Study — Running, not enrolling
• Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) — Stopped early
• A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis — Completed
• Ultrasound Treatment on Wound Healing Time — Stopped early
• A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors — Stopped early
• Open Abdomen Study Comparing ABThera™ Open Abdomen Negative Pressure Therapy System and Barker's Vacuum Packing Technique — Completed
• Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury — Completed
• Evaluating Patients With Varying Degrees of Renal Function — Completed
• A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma — Stopped early
• ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors — Completed
• IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study — Running, not enrolling
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
• A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients — Completed
• The Bed Rest Avoidance Study — Completed
• A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer — Stopped early
• Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors — Stopped early
• Regular vs. Clear Liquid Diet for Mild to Moderate Acute Pancreatitis — Status unconfirmed
• Impact of AI on Trainee ADR — Status unconfirmed
• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping) — Status unconfirmed
• Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2 — Completed
• A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia — Completed
• A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer — Completed
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) — Completed
• Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 — Completed
• Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors — Stopped early
• Lactated Ringer's Versus Normal Saline for Acute Pancreatitis — Completed
• Pegfilgrastim in Patients With Alcoholic Hepatitis — Completed
• Implementing Precision Medicine Approaches to Guide Anti-platelet Selection — Status unconfirmed
• Early Caffeine in Preterm Neonates — Status unconfirmed
• Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer — Completed
• Late Preterm Corticosteroids and Neonatal Hypoglycemia — Status unconfirmed
• Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease — Completed
• A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer — Completed
• Evaluation of Prevent in Underserved Populations — Completed
• A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome — Completed
• A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer — Completed
• The SUCCEED Trial of Secondary Stroke Prevention — Completed
• Medical Clowns for Pediatric Blood Draw — Status unconfirmed
• Aquaresis Utility for Hyponatremic Acute Heart Failure Study — Completed
• ST266 Versus Standard Care In Treating Partial Thickness Burns — Stopped early
• Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial — Completed
• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — Completed
• A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed